Par Health USA, LLC
42 drugs in NADAC|39 Generic,3 Brand
View Recalls (1)Par Health USA, LLC lists 42 NDCs in the CMS NADAC file (39 generic, 3 brand), at an average NADAC of $3.72 per unit, with a week-over-week move of -1.8% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
42
39G / 3B
Avg Price / Unit
$3.7246
$0.03 – $35.75
Avg 7d Change
-1.84%
Across 31 drugs with changes
7d Activity
of 42 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Dexmethylphenidate Hydrochloride market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Central Nervous System Stimulant therapeutic class
Review the broader class where Par Health USA, LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Par Health USA, LLC make?
Par Health USA, LLC lists 42 NDCs in the CMS NADAC file — 39 generic and 3 brand products.
What is the average price of Par Health USA, LLC drugs?
The average NADAC across Par Health USA, LLC's portfolio is $3.7246 per unit, ranging from $0.0315 to $35.7528.
What types of drugs does Par Health USA, LLC make?
Par Health USA, LLC makes drugs across 14 FDA pharmacologic classes. The most common by NDC count are Central Nervous System Stimulant (8), Kinase Inhibitor (5), mTOR Inhibitor Immunosuppressant (5), Benzodiazepine (5), Opioid Agonist (5).
Has Par Health USA, LLC had any drug recalls?
1 FDA recall is matched to Par Health USA, LLC in the openFDA feed, most recently on Jun 12, 2026.
How has Par Health USA, LLC's pricing changed recently?
Over the past 7 days, 11 Par Health USA, LLC products rose and 20 fell, with a portfolio-wide average change of -1.8%.
FDA Recalls (1)
Recalls matched by company name. Verify current status with FDA.
Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05
Crystallization; identified as Buprenorphine free base